Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis
- 8 January 2018
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 57 (5) , 814-820
Abstract
Introduction: Agrin is essential for the formation and maintenance of neuromuscular junctions (NMJs). NT‐1654 is a C‐terminal fragment of mouse neural agrin. In this study, we determined the effects of NT‐1654 on the severity of experimental autoimmune myasthenia gravis (EAMG). Methods: EAMG was induced in female Lewis rats by immunization with the Torpedo acetylcholine receptor (tAChR) and complete Freund's adjuvant (CFA). NT‐1654 was dissolved in phosphate‐buffered saline (PBS) and injected daily subcutaneously into tAChR immunized rats during the first 10 days after immunization, and then every other day for the following 20 days. Results: We showed that NT‐1654 attenuated clinical severity, effectively promoted the clustering of AChRs at NMJs, and alleviated the impairment of NMJ transmission and the reduction of muscle‐specific kinase (MuSK) in EAMG rats. Discussion: We demonstrated that NT‐1654 attenuated clinical severity, effectively promoted the clustering of AChRs at NMJs, and alleviated the impairment of NMJ transmission and the reduction of muscle‐specific kinase (MuSK) in EAMG rats. Muscle Nerve 57: 814–820, 2018Keywords
Funding Information
- US (R01NS092713)
- American Heart Association (16SDG27250236)
- National Multiple Sclerosis Society (RG‐1507‐05318)
- Genzyme
This publication has 33 references indexed in Scilit:
- The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapsesProceedings of the National Academy of Sciences, 2014
- Injection of a Soluble Fragment of Neural Agrin (NT-1654) Considerably Improves the Muscle Pathology Caused by the Disassembly of the Neuromuscular JunctionPLOS ONE, 2014
- Antibodies against low-density lipoprotein receptor–related protein 4 induce myasthenia gravisJournal of Clinical Investigation, 2013
- Autoimmune mechanisms in myasthenia gravisCurrent Opinion in Neurology, 2012
- Specific proteolytic cleavage of agrin regulates maturation of the neuromuscular junctionJournal of Cell Science, 2010
- LRP4 Serves as a Coreceptor of AgrinNeuron, 2008
- Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardationThe FASEB Journal, 2007
- Myasthenia gravis: past, present, and futureJournal of Clinical Investigation, 2006
- Myasthenia gravisThe Lancet, 2001
- Agrin Acts via a MuSK Receptor ComplexCell, 1996